Global Market Study on Generic Oncology Drugs: Improved Drug Manufacturing Infrastructure and Favorable Government Policies Reinforcing Demand


  • Rep Id : XPLREP3193
  • Published On : November, 2018
  • No. of Pages : 176
  • Category : Drug Discovery
  • Publisher : Persistence Market Research

A recent market study published by the company titled “Generic Oncology Drugs Market: Global Industry Analysis 2013–2017 and Forecast 2018–2028” consists of a comprehensive assessment of the most important dynamics of the Generic Oncology Drugs market. Upon conducting comprehensive research on the current growth parameters of the Generic Oncology Drugs market, the growth prospects of the market are obtained with maximum precision. The report features the unique and salient factors that are likely to have a significant impact on the development of the concerned market during the forecast period. The report provides detailed information about the current and future growth prospects of the concerned market in the most comprehensive manner for the better understanding of readers.

Chapter 1 – Executive Summary

The report commences with an executive summary of the Generic Oncology Drugs market report, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) of the leading segments of the Generic Oncology Drugs market.

Chapter 2 – Market Introduction

Readers can find a detailed taxonomy and definition of Generic Oncology Drugs products in this chapter, which will help them understand the basic information about the concerned market. The definition section considers the factors included as well as excluded for the purpose of this report.

Chapter 3 – Market Opportunity Analysis

This section of the report provides readers an outlook of the global Generic Oncology Drugs market, taking into consideration the various factors associated with the growth, which will help them track the current market scenario, with key inferences drawn from historical data, current trends and future prospects. This section also consists of an opportunity analysis conducted by XploreMR. Readers can find various macro-economic factors associated with the growth of the market

Chapter 4 – Market Background

This chapter highlights the key market dynamics, which include the drivers, restraints and trends. In this chapter, readers can understand the factors that are propelling the growth of the market along with the factors that are likely to deter the growth of the market. Moreover, readers will understand the key trends followed by the leading manufacturers in the Generic Oncology Drugs market. Key pointers, such as PESTLE Analysis and Regulatory Scenario, are also included in the report.

Chapter 5 – Key Inclusions

This chapter shows the Generic Oncology Drugs Pipeline on a much broader scale with regular details.

Chapter 6 – North America Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes a detailed analysis of the growth of the North America Generic Oncology Drugs market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find historical trends and market attractiveness based on molecule type, route of administration and distribution channel for the North America region.

Chapter 7 – Western Europe Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

Important growth prospects of the Generic Oncology Drugs market with market attractiveness based on molecule type, route of administration and distribution channel in several Western European countries, such as Spain, UK, Germany, Italy, France and the Rest of Western Europe, are included in this chapter.

Chapter 8 – Eastern Europe Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

Important growth prospects of the Generic Oncology Drugs market with market attractiveness based on molecule type, route of administration and distribution channel in several Eastern European countries. 

Chapter 9 – Latin America Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes a detailed analysis of the growth of the Latin America Generic Oncology Drugs market along with a country-wise assessment that includes Brazil and Mexico. Readers can also find historical trends and market attractiveness based on molecule type, route of administration and distribution channel of Generic Oncology Drugs in the Latin American region.

Chapter 10 – APECJ Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

India, ASEAN and Australia & New Zealand are the leading countries in the APECJ region that are the prime subject of assessment to obtain growth prospects for the APECJ Generic Oncology Drugs market. In this chapter, readers can find detailed information about the growth parameters.

Chapter 11 – China Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

Readers can find important factors that can have a significant impact on the growth of the Generic Oncology Drugs market in China based on molecule type, route of administration and distribution channel of Generic Oncology Drugs during the forecast period

Chapter 12 – Japan Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

Readers can find important factors that can have a significant impact on the growth of the Generic Oncology Drugs market in Japan based on the market segmentation during the forecast period.

Chapter 13 – MEA Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

This chapter provides information about how the Generic Oncology Drugs market will grow in the major countries in the MEA region, such as GCC Countries and South Africa, during the period 2013-2028.

Chapter 14 – Forecast Factors: Relevance and Impact

 Forecast factors set for the estimation of the entire concerned market are also present in this section.

Chapter 15 – Forecast Assumptions

Global assumptions taken in order to obtain the market size and scenario for Generic Oncology Drugs market

Chapter 16 – Competition Analysis

In this chapter, along with detailed information about each company, including company overview, revenue shares, strategic overview and recent company developments for Generic Oncology Drugs. Market players featured in this report include Novartis, Pfizer, GSK, Celegne, Teva Pharmaceutical, Merck & Company, Aurobindo Pharma, Hikma Pharmaceuticals, Mylan and Natco Pharma

Chapter 17 – Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028, By Region

This section highlights Global Generic Oncology Drugs value in different regions, the overall global market value (US$ Mn), forecast and analysis.

Based on the Region, the Generic Oncology Drugs market is segmented into North America, Latin America, Western Europe, Eastern Europe, APECJ, Japan, China and MEA.

Chapter 18 – Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type

Based on Molecule Type, the Global Generic Oncology Drugs market is segmented into large molecule and small molecule.

Chapter 19 – Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration

Based on Route of Administration, the Global Generic Oncology Drugs market is segmented into Oral and Parenteral.

Chapter 20 – Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

Based on Distribution Channel, the Global Generic Oncology Drugs market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Managed Care Institutions.

Chapter 21 – Global Generic Oncology Drugs Market Analysis and Forecast

This section highlights the Generic Oncology Drugs market value, the overall global Absolute $ Opportunity, forecast and analysis.

Chapter 22 – Assumptions and Acronyms Used

This section consists of a glossary of assumptions and acronyms used in the Generic Oncology Drugs market report.

Chapter 23 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information and quantitative information about the Generic Oncology Drugs market.